Related Experiment Videos
Prevention of acute renal failure in the critically ill
Claudio Ronco1, Rinaldo Bellomo
1Divisione di Nefrologia, Ospedale San Bortolo, Vicenza, Italy. rinaldo.bellomo@armc.org.au
Abstract:
Acute renal failure (ARF) is a common and important complication of critical illness and many interventions have been proposed to prevent it. The pathogenesis of acute renal failure during critical illness is poorly understood. Animal models are based on the induction of renal ischemia and do not reflect the dominance of sepsis as a cause of ARF in the clinical arena. Although biological rationale exists for several interventions, none have been shown to be effective in large randomized double-blind multicentre trials. The only interventions with close to level I evidence are confined to the attenuation of radiocontrast nephropathy. The effect on such interventions is, however, of limited clinical relevance to critically ill patients. The maintenance of adequate intravascular filling, cardiac output and renal perfusion pressure and the avoidance of hypoxemia, marked anemia and nephrotoxins remain the only justifiable interventions at this time.
Insights
Preventing acute renal failure (ARF) in critically ill patients is challenging, as current interventions lack proven efficacy. Maintaining organ perfusion and avoiding nephrotoxins are the only recommended strategies for acute kidney injury prevention.
Area of Science:
- Nephrology
- Critical Care Medicine
- Renal Pathophysiology
Background:
- Acute renal failure (ARF) is a frequent complication in critically ill patients.
- The underlying mechanisms of ARF in critical illness are not well understood.
- Existing animal models do not accurately represent sepsis-induced ARF, which is prevalent clinically.
Purpose of the Study:
- To review the current understanding of acute renal failure (ARF) in critical illness.
- To evaluate the effectiveness of proposed interventions for preventing ARF.
- To identify evidence-based strategies for ARF prevention in critically ill patients.
Main Methods:
- Review of existing literature on ARF in critical illness.
- Analysis of randomized controlled trials (RCTs) for ARF prevention strategies.
- Assessment of the clinical relevance of interventions, particularly for radiocontrast nephropathy.
Main Results:
- Many proposed interventions for ARF lack proven efficacy in large-scale trials.
- Animal models of renal ischemia do not fully replicate clinical ARF, often caused by sepsis.
- Limited evidence supports interventions for radiocontrast nephropathy, with questionable relevance to critically ill patients.
Conclusions:
- Current evidence does not support specific pharmacological interventions for preventing ARF in critical illness.
- Maintaining adequate physiological parameters is crucial for renal protection.
- Key interventions include ensuring adequate intravascular volume, cardiac output, renal perfusion pressure, and avoiding hypoxemia, severe anemia, and nephrotoxic agents.